Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

EIF4E antibody

This anti-EIF4E antibody is a Rabbit Polyclonal antibody detecting EIF4E in IHC. Suitable for Human, Rat and Mouse. This Primary Antibody has been cited in 3+ publications.
Catalog No. ABIN966057

Quick Overview for EIF4E antibody (ABIN966057)

Target

See all EIF4E Antibodies
EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))

Reactivity

  • 125
  • 63
  • 51
  • 19
  • 5
  • 5
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
Human, Rat, Mouse

Host

  • 109
  • 15
  • 2
Rabbit

Clonality

  • 99
  • 27
Polyclonal

Conjugate

  • 60
  • 9
  • 8
  • 6
  • 5
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This EIF4E antibody is un-conjugated

Application

  • 99
  • 52
  • 44
  • 28
  • 27
  • 26
  • 16
  • 16
  • 16
  • 14
  • 7
  • 6
  • 2
  • 1
Immunohistochemistry (IHC)
  • Specificity

    ElF4E (Ab-209) antibody detects endogenous levels of total elF4E protein.

    Purification

    The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

    Immunogen

    The antiserum was produced against synthesized non-phosphopeptide derived from human elF4E around the phosphorylation site of serine 209 (S-G-SP-T-T).
  • Application Notes

    WB: 1:500~1:1000
    IHC: 1:50~1:100.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    100ug/100ul.

    Buffer

    Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C
  • Gu, Li, Zhao, Fang, Bu, Frazer, Zhao: "tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes." in: Nucleic acids research, Vol. 32, Issue 15, pp. 4448-61, (2004) (PubMed).

    Li, McDonald, Nassar, De Benedetti: "Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression." in: Annals of surgery, Vol. 227, Issue 5, pp. 756-6l; discussion 761-3, (1998) (PubMed).

    Ohlmann, Rau, Pain, Morley: "The C-terminal domain of eukaryotic protein synthesis initiation factor (eIF) 4G is sufficient to support cap-independent translation in the absence of eIF4E." in: The EMBO journal, Vol. 15, Issue 6, pp. 1371-82, (1996) (PubMed).

  • Target

    EIF4E (Eukaryotic Translation Initiation Factor 4E (EIF4E))

    Pathways

    BCR Signaling
You are here:
Chat with us!